Company Search:
Advanced Search
Sponsored Links
Orexo Ab Company Snapshot
Orexo Ab operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Orexo Ab with three other pharmaceutical manufacturers in Europe: Vectura Group PLC of the United Kingdom (2015 sales of £58.00 million [US$70.99 million] of which 100% was Pharmaceutical Prod), Quantum Pharma PLC of the United Kingdom (£61.72 million [US$75.54 million] of which 77% was B Manufacture and supply of niche pharma), and Bosnalijek d.d. Sarajevo which is based in Bosnia (126.67 million Bosnian Convertible Marks [US$71.12 million] ).

Sales Analysis. During the year ended December of 2015, sales at Orexo Ab were SEK 643.34 million (US$72.12 million). This is an increase of 12.8% versus 2014, when the company's sales were SEK 570.32 million. This was the fourth straight year of sales growth at Orexo Ab. Sales of Zubsolv saw an increase that was more than double the company's growth rate: sales were up 82.8% in 2015, from SEK 228.00 million to SEK 416.70 million. Orexo Ab also saw significant increases in sales in Royalty - Edluar (up 27.1% to SEK 13.60 million) . Not all segments of Orexo Ab experienced an increase in sales in 2015: sales of Kibion Ab fell 75.0% to SEK 12.80 million. Orexo Ab also experienced decreases in sales in Royalty - Abstral (down 39.1% to SEK 134.20 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Orexo Ab
  Stock Performance Chart for Orexo Ab
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 49.20
(Figures in Swedish Kronor)
1 Week 12.6%   13 Weeks 2.5%  
4 Weeks -1.0%   52 Weeks -14.4%  
Orexo Ab Key Data:
  Ticker: ORX Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 643,338,000
(Year Ending Jan 2016).
Employees: 90
  Currency: Swedish Kronor Market Cap: 1,705,572,464
  Fiscal Yr Ends: December Shares Outstanding: 34,666,107
  Share Type: Aktie Closely Held Shares: 3,590,091
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.